WallStreetZenWallStreetZen

NASDAQ: NRIX
Nurix Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for NRIX

Based on 8 analysts offering 12 month price targets for Nurix Therapeutics Inc.
Min Forecast
$11.00-12.14%
Avg Forecast
$32.13+156.59%
Max Forecast
$53.00+323.32%

Should I buy or sell NRIX stock?

Based on 8 analysts offering ratings for Nurix Therapeutics Inc.
Buy
Strong Buy
2 analysts 25%
Buy
5 analysts 62.5%
Hold
1 analysts 12.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NRIX stock forecasts and price targets.

NRIX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
SVB Leerink
Bottom 2%
2
BuyMaintains$28.00+123.64%2022-12-13
Morgan Stanley
Top 27%
74
HoldInitiates Coverage On$11.00-12.14%2022-10-11
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$53.00+323.32%2022-10-07
Needham
Top 32%
69
BuyMaintains$32.00+155.59%2022-07-12
Baird
Top 17%
84
BuyMaintains$32.00+155.59%2022-07-08
JP Morgan
Bottom 6%
6
Strong BuyMaintains$37.00+195.53%2022-07-08
Wells Fargo
Top 1%
100
Strong BuyUpgrades$25.00+99.68%2022-05-31
RBC Capital
Top 12%
89
BuyMaintains$39.00+211.50%2022-04-18

1 of 1

Forecast return on equity

Is NRIX forecast to generate an efficient return?
Company
N/A
Industry
-0.01%
Market
13.24%

Forecast return on assets

Is NRIX forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

NRIX earnings per share forecast

What is NRIX's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$3.94
Avg 2 year Forecast
-$4.38
Avg 3 year Forecast
-$5.38

NRIX revenue forecast

What is NRIX's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$72.0M+83.4%
Avg 2 year Forecast
$112.9M+187.61%
Avg 3 year Forecast
$88.1M+124.52%
NRIX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NRIX revenue growth forecast

How is NRIX forecast to perform vs Biotechnology companies and vs the US market?
Company
57.65%
Industry
38.5%
Market
9.23%
NRIX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NRIX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NRIX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NRIX$12.52$32.13+156.59%Buy
ZYME$9.48$16.90+78.27%Strong Buy
ARCT$21.97$36.71+67.11%Buy
NKTR$3.09$7.43+140.42%Hold
AVTE$24.51$27.00+10.16%Strong Buy

Nurix Therapeutics Stock Forecast FAQ

Is Nurix Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: NRIX) stock is to Buy NRIX stock.

Out of 8 analysts, 2 (25%) are recommending NRIX as a Strong Buy, 5 (62.5%) are recommending NRIX as a Buy, 1 (12.5%) are recommending NRIX as a Hold, 0 (0%) are recommending NRIX as a Sell, and 0 (0%) are recommending NRIX as a Strong Sell.

If you're new to stock investing, here's how to buy Nurix Therapeutics stock.

What is NRIX's earnings growth forecast for 2023-2025?

(NASDAQ: NRIX) Nurix Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 21.99%.

Nurix Therapeutics's earnings in 2023 is -$171,345,000.On average, 4 Wall Street analysts forecast NRIX's earnings for 2023 to be -$185,762,257, with the lowest NRIX earnings forecast at -$239,982,205, and the highest NRIX earnings forecast at -$159,830,978. On average, 4 Wall Street analysts forecast NRIX's earnings for 2024 to be -$206,507,281, with the lowest NRIX earnings forecast at -$301,745,798, and the highest NRIX earnings forecast at -$151,344,377.

In 2025, NRIX is forecast to generate -$253,655,062 in earnings, with the lowest earnings forecast at -$283,829,642 and the highest earnings forecast at -$207,450,236.

What is NRIX's revenue growth forecast for 2023-2025?

(NASDAQ: NRIX) Nurix Therapeutics's forecast annual revenue growth rate of 57.65% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.5%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.23%.

Nurix Therapeutics's revenue in 2023 is $39,240,000.On average, 4 Wall Street analysts forecast NRIX's revenue for 2023 to be $3,392,990,060, with the lowest NRIX revenue forecast at $1,296,563,978, and the highest NRIX revenue forecast at $5,530,906,189. On average, 3 Wall Street analysts forecast NRIX's revenue for 2024 to be $5,321,004,268, with the lowest NRIX revenue forecast at $2,545,980,174, and the highest NRIX revenue forecast at $8,569,109,197.

In 2025, NRIX is forecast to generate $4,153,719,506 in revenue, with the lowest revenue forecast at $3,536,083,575 and the highest revenue forecast at $4,771,355,437.

What is NRIX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: NRIX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.

What is NRIX's Price Target?

According to 8 Wall Street analysts that have issued a 1 year NRIX price target, the average NRIX price target is $32.13, with the highest NRIX stock price forecast at $53.00 and the lowest NRIX stock price forecast at $11.00.

On average, Wall Street analysts predict that Nurix Therapeutics's share price could reach $32.13 by Dec 13, 2023. The average Nurix Therapeutics stock price prediction forecasts a potential upside of 156.59% from the current NRIX share price of $12.52.

What is NRIX's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: NRIX) Nurix Therapeutics's current Earnings Per Share (EPS) is -$3.71. On average, analysts forecast that NRIX's EPS will be -$3.94 for 2023, with the lowest EPS forecast at -$5.09, and the highest EPS forecast at -$3.39. On average, analysts forecast that NRIX's EPS will be -$4.38 for 2024, with the lowest EPS forecast at -$6.40, and the highest EPS forecast at -$3.21. In 2025, NRIX's EPS is forecast to hit -$5.38 (min: -$6.02, max: -$4.40).

What is NRIX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: NRIX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.